ISSN: 2456-7264 | Issue – 21 | Published On 05/09/2022 |
Research Highlights New platform to edit mitochondrial DNA Nobel Prize was awarded in 2020 for development of gene editing technology ‘CRISPR/Cas9’. Although, CRISPR/Cas9 technology has revolutionized the process of genome editing, it was restricted to nuclear genome, and mitochondrial DNA was untouched as the guide RNA is not capable to enter the
Read More
Research Highlights Unrevealing the genesis of “Omicron” By the end of 2021, the world has understood the impact of COVID-19 in most of the dimensions of life; however, there are many mysteries in the genesis, virulence, pathogenesis, evolution and mutation of SARS-CoV-2. Since 2020, we are experiencing new heats of COVID-19 in
Read More
Research Highlights The most awaited day to end Malaria has arrived Malaria is caused by Plasmodium group of parasites and it is one of the deadly infectious diseases of human transmitted by mosquitoes. Annually, more than 200 million cases and 400,000 deaths are reported worldwide. But after many decades of research, the
Read More
Status of new therapeutics to fight COVID-19 Most of the newly developed COVID-19 vaccines are showing promising results in controlling the pandemic across the globe. However, the hunt for potent and effective therapeutics against COVID-19 is still on because availability of effective therapeutic agent(s) is also a pre-requisite to end the
Read More
Novel Escherichia coli to produce animal origin drug Chondroitin sulfate (CS), a kind of sulphated glycosaminoglycans (GAGs), is a component of joint tissues in human. CS has therapeutic value and is commonly used in the treatment of osteoarthritis. Not only CS but also most of the commercial GAGs are extracted from
Read More
Self-testing COVID-19 kit The US Food and Drug Administration (FDA) have approved the first self-testing COVID-19 diagnostic kit to be used at home. It is a molecular test based on real-time loop mediated amplification reaction for detection of SARS-COV-2. The kit is commercialized as the Lucira COVID-19 All-In-One Test Kit intended
Read More
Research Highlights Intranasal vaccine against SARS-CoV-2 Virus The world scientific community is in hunt for COVID-19 vaccine. Although many vaccine candidates are in clinical trials, the hunt for newer ones is still in progress. In this regard, researchers from Washington University School of Medicine (St. Louis) have examined the efficacy of a
Read More
Hunt for COVID-19 vaccines Vaccination is the most effective way to control viral diseases. But it is challenging to develop a potent vaccine against any novel virus such as novel coronavirus (SARS-CoV2), which is causing pandemic and a threat to the mankind. Thrust of COVID-19 has ignited the race among the
Read More
Designed mosquito to combat dengue Dengue fever caused by Dengue virus (DENV) is a mosquito-borne tropical disease. Globally, millions of people are infected by dengue virus and thousands of people die every year. Dengue fever is mainly spread by female mosquitoes, principally Aedes aegypti. One of the preventive measures to control
Read More
The Artificial Leaf A scientific team from University of Cambridge have invented a carbon-neutral device called Artificial Leaf for production of synthetic gas (syngas). Basically, syngas is a mixture of hydrogen, carbon dioxide and carbon monoxide, and used in production of fuels, pharmaceuticals, plastics and fertilisers. The device is based on
Read More